DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 142 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2017. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $5,961,000 | +91.4% | 277,288 | -14.1% | 0.48% | +146.4% |
| Q2 2017 | $3,114,000 | +29.3% | 322,746 | -20.3% | 0.20% | +5.4% |
| Q1 2017 | $2,409,000 | +46.6% | 404,930 | -2.6% | 0.19% | +60.3% |
| Q4 2016 | $1,643,000 | -82.8% | 415,893 | -54.4% | 0.12% | -79.8% |
| Q3 2016 | $9,561,000 | -49.1% | 911,326 | -29.3% | 0.57% | -57.7% |
| Q2 2016 | $18,791,000 | -16.6% | 1,288,771 | +10.1% | 1.36% | -0.6% |
| Q1 2016 | $22,520,000 | +90.6% | 1,170,440 | +139.3% | 1.37% | +55.8% |
| Q4 2015 | $11,815,000 | +8.9% | 489,050 | +10.6% | 0.88% | +3.2% |
| Q3 2015 | $10,848,000 | +9.0% | 442,065 | +4.0% | 0.85% | +21.1% |
| Q2 2015 | $9,953,000 | – | 424,907 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |